Strive Enterprises / Asset Entities $750 million committed PIPE financing
We advised Strive Enterprises on the transaction involving common stock, pre-funded warrants and traditional warrants
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
QXO $1.495 billion common and depositary share offerings
The common stock is listed on the NYSE
Atara Biotherapeutics registered direct offering
The stock is listed on Nasdaq
Ameren $586.5 million stock offering and forward sale agreements
The shares are listed on the NYSE
Somnigroup International $953 million secondary offering
The shares are listed on the New York Stock Exchange
Middlesex Water $110 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
CytomX Therapeutics $100 million stock offering
The stock is listed on the Nasdaq Global Select Market
Primo Brands $1.5 billion secondary offering
The shares are listed on the New York Stock Exchange
NOVAGOLD $243.8 million upsized public offering and concurrent private placement
The shares are listed on the New York Stock Exchange American and the Toronto Stock Exchange
Strategy $21 billion at-the-market offering
The stock is listed on the Nasdaq Global Select Market